NCT06055400 is a NA clinical trial of AR-US in Healthy, sponsored by Shu-Chen Liao.

Who is sponsoring NCT06055400?

NCT06055400 is sponsored by Shu-Chen Liao.

What drugs are being tested in NCT06055400?

Interventions in NCT06055400: AR-US.

Is NCT06055400 still recruiting?

NCT06055400 is currently completed. Last updated 26 September 2023.

Last reviewed 2023-09-26 · How we verify

NCT06055400

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

An Investigation of Trainees' Performance in Augmented Reality Simulation for Invasive Procedure Training

Completed NA Last updated 26 September 2023

What this trial tests

NA trial testing AR-US in Healthy in 47 participants. Completed in 31 December 2022.

Timeline

1 August 2021

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Shu-Chen Liao
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	other
Enrollment	47
Start date	1 August 2021
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	1 location across Taiwan

Drugs / interventions tested

AR-US

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Shu-Chen Liao

Who can join

Adults 20 to 65, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of this study is to measure the efficacy of augmented reality technology in ultrasound-guided medical intervention.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Augmented reality visualization for ultrasound-guided interventions: a pilot randomized crossover trial to assess trainee performance and cognitive load.
Liao SC, Shao SC, Gao SY, Lai EC. · · 2024 · cited 13× · PMID 39334275 · DOI 10.1186/s12909-024-05998-8

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06055400 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shu-Chen Liao
Last refreshed: 26 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06055400.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing